These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3045278)

  • 21. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
    van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging for axillary staging in patients with breast cancer.
    Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR
    J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
    Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carnoy's solution fixation with compression significantly increases the number of lymph nodes yielded from colorectal cancer specimens.
    Flynn SM; Burchette RJ; Ghassemi M; Ratner O; Mandel D; Tomassi MJ; Klaristenfeld DD
    J Surg Oncol; 2019 May; 119(6):766-770. PubMed ID: 30650183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node revealing solution in gastric carcinoma does not provide upstaging of the N-status.
    Luebke T; Baldus SE; Zirbes TK; Pham TD; Schneider PM; Dienes HP; Hölscher AH; Mönig SP
    Oncol Rep; 2005 Feb; 13(2):361-5. PubMed ID: 15643525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Axillary lymph nodes in breast cancer. Comparison of standard histological analytical technics and macroscopic serial sections].
    de Mascarel I; Trojani M; Abadjian G; Durand M; Bonichon F; Coindre JM; Meuge-Moraw C
    Bull Cancer; 1982; 69(5):451-5. PubMed ID: 6762234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axillary lymphectomy in breast cancer.
    Barillari P; Leuzzi R; D'Angelo F; Bassiri-Gharb A; Naticchioni E
    Minerva Chir; 2002 Apr; 57(2):129-33. PubMed ID: 11941288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis].
    Wu WJ; Zeng J; Pan CE
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1812-4. PubMed ID: 17259127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
    Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
    Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
    Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lymph node ratio as prognostic factor in node-positive breast cancer.
    Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G
    Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
    Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.